A cattle virus has reached a person for the first time. Here is why health officials say the risk is low

This story begins with a loss. A patient at the Hospices Civils de Lyon, already very ill, died in early October. Doctors had found something no one had seen before: the Shamonda virus, until now known only in animals, in a human being.

French health authorities announced the case on 22 October. The European Centre for Disease Prevention and Control (ECDC) calls it the first ever reported human infection. It matters because the virus has spread fast among European farm animals this year. It is also a case where calm facts help more than fear.

What is Shamonda virus, and where has it spread?

Shamonda virus was first identified in Nigeria in the 1960s, according to Santé publique France, the national public health agency. It belongs to a family of viruses carried by tiny biting flies called midges (Culicoides). It mainly affects cattle, sheep and goats. In animals, Shamonda virus symptoms include fever, diarrhoea, less milk, and miscarriages or birth defects in their young.

A new form of the virus reached Europe in summer 2026. Animals showed signs from June, and the virus was identified in late July. ECDC says it has since been found in farm animals in 12 countries, from Ireland and Portugal to Austria and Italy, as well as Jersey. In France alone, as of 20 October, it had been found in cattle in 52 departments, sheep in two and one horse.

A rare case in a very vulnerable patient

The patient had a severely weakened immune system after a stem cell transplant. Health authorities were told about the infection on 7 October.

A case report in the journal Eurosurveillance gives the medical detail. The patient developed encephalitis, a swelling of the brain, in September, one month after the transplant. The Lyon team found the virus through deep genetic testing of the fluid around the brain and spine. Looking back, they also found it in blood, airway and stool samples from at least two months before the brain illness began.

What we don’t know yet matters just as much. ECDC says investigators are still working out whether the virus caused or contributed to the death.

How the patient caught it is also still open. The leading idea, according to Santé publique France, is a bite from an infected midge. Other routes are still being checked, including travel and contact with animals. ECDC says the midge species involved is not yet known.

Should you worry about Shamonda virus in humans?

For almost everyone, the honest answer is no. Santé publique France says there is “no evidence to suggest human-to-human transmission or a health risk to the general population.” ECDC points out that the patient’s illness made them more likely to catch infections, and to suffer from them, than most people.

The season helps too. Midges are most active from spring to autumn, and ECDC says most species are becoming less active as Europe cools.

If you farm or work with animals in Europe, the usual advice stands: tell your vet about sick animals. If you or someone you care for has a very weak immune system, your own doctor is the best person to ask about any extra care. Please don’t change any treatment based on a news story.

Why this case shows the system working

This analysis starts with what went right. A hospital team used advanced genetic tools to name a virus no one expected. Officials shared the case within weeks, with clear words about risk. That openness builds trust.

There is a harder side. Until now, experts believed this virus did not infect people at all. One case cannot tell us whether others have been missed, which is why France’s national reference centre is improving its tests and ECDC is helping countries look for any other cases.

On balance, this is a moment for careful attention, not alarm. Viruses in animals sometimes reach people, and the best defence is doctors, vets and insect experts sharing what they find, an approach known as “One Health”. Like the melanoma vaccine trial we covered this week, it also shows how much modern medicine now relies on reading genetic code.

Next, scientists will read the patient’s full viral genome and compare it with strains found in animals. Those results, and whether any second case appears, are what to watch.